Risk factors for long-term cognitive impairment in ICU survivors: A multicenter, prospective cohort study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Risk factors for long-term cognitive impairment in ICU survivors : A multicenter, prospective cohort study. / Collet, Marie O.; Egerod, Ingrid; Thomsen, Thordis; Wetterslev, Jørn; Lange, Theis; Ebdrup, Bjørn H.; Perner, Anders.
In: Acta Anaesthesiologica Scandinavica, Vol. 65, No. 1, 2021, p. 92-99.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Risk factors for long-term cognitive impairment in ICU survivors
T2 - A multicenter, prospective cohort study
AU - Collet, Marie O.
AU - Egerod, Ingrid
AU - Thomsen, Thordis
AU - Wetterslev, Jørn
AU - Lange, Theis
AU - Ebdrup, Bjørn H.
AU - Perner, Anders
PY - 2021
Y1 - 2021
N2 - Purpose: To describe the incidence of and risk factors for impaired cognitive function in intensive care unit (ICU) survivors. We hypothesized that age, severity of illness, and days in coma, delirium, mechanical ventilation in the ICU would be associated with impaired cognitive function. Methods: We included all adults, alive 6 months after acute admission to one of the 24 Danish ICUs participating in the AID-ICU cohort study. Trained professionals assessed cognitive function in patients’ homes or in outpatient clinics using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) 6 months after ICU admission. Potential risk factors for cognitive impairment were analyzed with linear regression models. Results: In total, 237 ICU patients were alive 6 months after ICU admission and did not meet the exclusion criteria. A total of 106 patients completed the cognitive assessment. The median RBANS global cognitive score was 76 (interquartile range, 62-91), and 52% had a global cognitive score 1.5 SD below the normative mean and 36% displayed a global cognitive score 2 SD below the normative mean, similar to that of Alzheimer's disease. Higher age was associated with poorer RBANS global cognitive score (estimate −0.35 [95% confidence interval −0.63 to −0.07] per year). Conclusions: In this multicenter study of adult ICU survivors, cognitive impairment was frequent and severe in those assessed at 6 months. Higher age was a risk factor for cognitive impairment, but events related to the ICU stay were not associated with poorer cognitive performance at 6 months.
AB - Purpose: To describe the incidence of and risk factors for impaired cognitive function in intensive care unit (ICU) survivors. We hypothesized that age, severity of illness, and days in coma, delirium, mechanical ventilation in the ICU would be associated with impaired cognitive function. Methods: We included all adults, alive 6 months after acute admission to one of the 24 Danish ICUs participating in the AID-ICU cohort study. Trained professionals assessed cognitive function in patients’ homes or in outpatient clinics using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) 6 months after ICU admission. Potential risk factors for cognitive impairment were analyzed with linear regression models. Results: In total, 237 ICU patients were alive 6 months after ICU admission and did not meet the exclusion criteria. A total of 106 patients completed the cognitive assessment. The median RBANS global cognitive score was 76 (interquartile range, 62-91), and 52% had a global cognitive score 1.5 SD below the normative mean and 36% displayed a global cognitive score 2 SD below the normative mean, similar to that of Alzheimer's disease. Higher age was associated with poorer RBANS global cognitive score (estimate −0.35 [95% confidence interval −0.63 to −0.07] per year). Conclusions: In this multicenter study of adult ICU survivors, cognitive impairment was frequent and severe in those assessed at 6 months. Higher age was a risk factor for cognitive impairment, but events related to the ICU stay were not associated with poorer cognitive performance at 6 months.
U2 - 10.1111/aas.13692
DO - 10.1111/aas.13692
M3 - Journal article
C2 - 32852053
AN - SCOPUS:85090758942
VL - 65
SP - 92
EP - 99
JO - Acta Anaesthesiologica Scandinavica
JF - Acta Anaesthesiologica Scandinavica
SN - 0001-5172
IS - 1
ER -
ID: 248932453